Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2013. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a comprehensive financial report.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial data present relates to a specific share transaction:
- Share Purchase Price: 1743.15 pence per share.
- Transaction Date: July 16, 2013.
- Shares Acquired: 26.087 ordinary shares.
Material Changes
The filing reports an increase in the interest of a connected person, Mrs. K Thomson, in GlaxoSmithKline plc ordinary shares. This increase resulted from the re-investment of the dividend paid to shareholders on July 11, 2013. No other material changes to the company's financial position or operations are disclosed in this document.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, outlook, or discussion of risks and contingencies. It is strictly a regulatory disclosure of a connected person's shareholding change in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investor Verification
- Verify the dividend reinvestment plan details for the July 11, 2013 payment.
- Confirm the total shareholding of Mrs. K Thomson following the acquisition of 26.087 shares.
- Note that this filing does not contain quarterly or annual financial performance data.